# Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

> **NCT03065478** · — · COMPLETED · sponsor: **Swiss Medical Food AG** · enrollment: 150 (actual)

## Conditions studied

- CIPN in Adjuvant Colon Cancer Patients
- CIPN in Adjuvant Breast Cancer Patients

## Interventions

- **DIETARY_SUPPLEMENT:** OnLife

## Key facts

- **NCT ID:** NCT03065478
- **Lead sponsor:** Swiss Medical Food AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-22
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03065478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03065478, "Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03065478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*